HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

samarium hydroxyapatite

a radiation synovectomy agent

Also Known As:

(153)Sm-PHYP; Sm-PHYP; samarium-153-particulate hydroxyapatite

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Assi, P E: 1 article (07/2013)
2.	Bordim, A: 1 article (07/2013)
3.	Gabriel, M B: 1 article (07/2013)
4.	Gutfilen, B: 1 article (07/2013)
5.	Lorenzato, C S: 1 article (07/2013)
6.	Mendes, J D: 1 article (07/2013)
7.	Pacheco, L R L: 1 article (07/2013)
8.	Souza, S A: 1 article (07/2013)
9.	Thomas, S: 1 article (07/2013)
10.	da Fonseca, L M B: 1 article (07/2013)

Related Diseases

1.	Synovitis 01/01/1995 - "Samarium-153-particulate hydroxyapatite radiation synovectomy: biodistribution data for chronic knee synovitis." 01/01/2011 - "The aim of the present study was to investigate the long-term effectiveness of and tolerance to Yttrium-90 and Samarium-153-particulate hydroxyapatite radiation synovectomy in patients with rheumatoid arthritis (RA) and chronic knee synovitis. "
2.	Rheumatoid Arthritis 01/01/2011 - "The aim of the present study was to investigate the long-term effectiveness of and tolerance to Yttrium-90 and Samarium-153-particulate hydroxyapatite radiation synovectomy in patients with rheumatoid arthritis (RA) and chronic knee synovitis. "
3.	Neoplasms (Cancer) 07/01/2013 - "Three centres in Brazil applied RS with (90) Yttrium Citrate, (90) Yttrium hydroxyapatite or (153) Samarium hydroxyapatite in haemophilic joints and performed a survey addressing cancer in these patients. "

Related Drugs and Biologics

1.	Yttrium-90
2.	Durapatite (Hydroxylapatite)
3.	Yttrium
4.	yttrium citrate

Related Therapies and Procedures

1.	Synovectomy